Recent advances in targeted strategies for triple-negative breast cancer
2023 · Journal of Hematology & Oncology · 254 citations
https://doi.org/10.1186/s13045-023-01497-3
Q
Qi Mei
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
252
Papers
4.8K
Citations
34
h-index
79
i10-index
Qi Mei is an academic researcher from Bengbu Medical College. The author has contributed to research in topics: Head and Neck Cancer Studies & Lung Cancer Research Studies & COVID-19 Clinical Research Studies. The author has an h-index of 34, co-authored 215 publications.
ORCID: 0000-0002-9826-5044Papers by this author
worksTargeting polarized phenotype of microglia via IL6/JAK2/STAT3 signaling to reduce NSCLC brain metastasis
2022 · Signal Transduction and Targeted Therapy · 154 citations
https://doi.org/10.1038/s41392-022-00872-9
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio
2015 · Head & Neck · 121 citations
https://doi.org/10.1002/hed.24224
Expression of midkine in the early stage of carcinogenesis in human colorectal cancer
1998 · British Journal of Cancer · 94 citations
https://doi.org/10.1038/sj.bjc.6690030
Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21
2020 · Molecular Therapy — Oncolytics · 51 citations
https://doi.org/10.1016/j.omto.2020.04.007
The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
2019 · BMC Cancer · 41 citations
https://doi.org/10.1186/s12885-019-6156-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat